Pennsylvania SB 1091: An Act providing for prescribing and dispensing drugs approved by the United States Food and Drug Administration for off-label use to treat coronavirus infections causing respiratory-syndrome-related illnesses.

Status: PN 1424 Referred to HEALTH AND HUMAN SERVICES (as of 2022-02-23)

State: Pennsylvania · Session: 2021-2022 · Bill: SB 1091

Sponsors: Mastriano, J. Ward, Phillips-Hill, Scavello, Stefano

View Pennsylvania SB 1091 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.